Subir Eyelash
FDA Label NDC 81716-004

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Dream Polymer for the product Subir Eyelash (NDC 81716-004). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient(s), purpose, use, warnings, otc - keep out of reach of children, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredient(S)

Biotin 10%

D-Panthenol 8%

Purpose

Anti-static, Hair conditioning, Skin conditioning

Use

Subir Eyelash Biotin Cream for eyelash damage care

Warnings

• Be careful not to get in your eyes.
• If it gets into your eyes, immediately wash it off with clean water several times.
• Wear appropriate gloves during the procedure.
• Do not eat.
• Keep out of reach of children.
• Store in a cool place away from direct sunlight.
• Recommended for single use only.
• For professional use only.
• Follow the recommendations.
• After use, if skin irritation such as rash or itching persists, stop use and consult a doctor or pharmacist

Otc - Keep Out Of Reach Of Children

 Keep out of reach of children.

Directions

• Using a Brush follow the same steps used for applying the perm and setting creams to applying the Essence (nourishing agent).
• Let nourishing set for five minutes.
• Prevents eyelash damage and promotes growth.

Other Information

・ Store in room temperature 0~30℃
・ Avoid direct sunlight.

Inactive Ingredients

Water, Propylene Glycol(PG), Acrus Calamus Rhizome Oil, Aloe Barbadensis (Aloe Vera) Leaf Juice, Chamaecyparis Obtusa Leaf Extract, Olea Europaea (Olive) Leaf Extract, Espinosilla Extract, Decametyl Tetra Siloxane, Fragrance

* Please review the disclaimer below.